Mundipharma Agreement And Drug Development Liability (Tables)

3 Months Ended

Mar. 31, 2016

Business Combinations [Abstract]

Schedule of Drug Development Liability Adjustments

	Drug Development Liability, Current – FOLOTYN			Drug Development Liability, Long Term – FOLOTYN			Total Drug Development Liability – FOLOTYN
Balance at December 31, 2015	$	259		$	14,427		$	14,686
Transfer from long-term to current in 2016	74			(74		)	—
(Less): Expenses incurred in 2016	(176		)	—			(176		)
Balance at March 31, 2016	$	157		$	14,353		$	14,510